Epizyme (EPZM) Tops Q2 EPS by 3c

August 8, 2016 6:31 AM EDT
Get Alerts EPZM Hot Sheet
Trade EPZM Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Epizyme (NASDAQ: EPZM) reported Q2 EPS of ($0.49), $0.03 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $473 thousand versus the consensus estimate of $888 thousand.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment